GEODE CAPITAL MANAGEMENT, LLC - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 11 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$158,784
+2.7%
178,262
+38.3%
0.00%
Q2 2023$154,675
-15.9%
128,896
+12.8%
0.00%
Q1 2023$183,940
+134162.8%
114,2490.0%0.00%
Q4 2022$137
-99.9%
114,249
-0.3%
0.00%
Q3 2022$193,000
+394.9%
114,563
+135.2%
0.00%
Q2 2022$39,000
-2.5%
48,716
+30.8%
0.00%
Q1 2022$40,00037,2450.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q2 2022
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders